Leeds Teaching Hospitals NHS Trust is conducting a six-month trial of a smartphone app aimed at monitoring and managing Parkinson’s disease symptoms, to provide more personalized patient care.
A total of 90 patients are participating in the trial of the Neu Health app, which commenced in March 2024 and will continue until September 2024, with potential further implementation pending evaluation results.
Parkinson’s disease is a progressive condition that damages parts of the brain, leading to symptoms like tremors, slow movement, and rigid muscles.
The app enables patients to track their symptoms for personal monitoring and clinical assessments. It also links with healthcare teams, allowing inputted data to be securely transmitted to Leeds Teaching Hospitals NHS Trust for comprehensive analysis.
Health professionals can access patient data and insights through a secure dashboard to provide tailored and effective treatment plans.
With the goal of enhancing care for Parkinson’s patients, the app includes personalized health information and digital tests to evaluate various aspects of the condition.
Dr. Jeremy Cosgrove, a consultant neurologist at Leeds Teaching Hospitals NHS Trust, expressed enthusiasm for the project, emphasizing the importance of exploring innovative ways to support patients with Parkinson’s disease.
Dr. Kinan Muhammed, chief medical officer and co-founder of Neu Health, highlighted the potential of this partnership to revolutionize neurology care delivery in the NHS.
According to patient Ian Bresloff, objective measures of Parkinson’s symptoms outside clinical settings are crucial for continuous monitoring and data-driven medication dosing.
Additionally, in February 2024, Leeds Teaching Hospitals NHS Trust initiated a collaboration with Clinisys’ WinPath laboratory information system to enhance its blood transfusion service.
